1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Clinical significance of stem cell biomarkers epcam, lgr5 and lgr4 mrna levels in lymph nodes of colon cancer patients
(
- Contribution to journal › Article
- 2020
-
Mark
Discrimination between breast cancer cells and white blood cells by non-invasive measurements : Implications for a novel in vitro-based circulating tumor cell model using digital holographic cytometry
(
- Contribution to journal › Article
- 2019
-
Mark
EPCAM mutation update : Variants associated with congenital tufting enteropathy and Lynch syndrome
(
- Contribution to journal › Article
-
Mark
The chemokine CXCL16 is a new biomarker for lymph node analysis of colon cancer outcome
(
- Contribution to journal › Article
-
Mark
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(15). p.7533-7542(
- Contribution to journal › Article
- 2017
-
Mark
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder : Association with tumor stage, lymph node metastases, FDG-PET findings, and survival
(
- Contribution to journal › Article
- 2016
-
Mark
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population
(
- Contribution to journal › Article